Circulating levels of Rivaroxaban provide different results in different clot based and amidolytic assays A study of 106 patients treated with two different dosing of Rivaroxaban


Syed D., Jezovnik M., Poredos P., Hoppensteadt D., TETİK Ş. , Iqbal O., ...Daha Fazla

Thrombosis Hemostasis, 10 - 12 Nisan 2014

  • Yayın Türü: Bildiri / Özet Bildiri